CELERA updated status as 4-02-01
CLIENT LIST
Pharma/Biotech Customers:
Amgen (Early Access Subscriber) (Multiyear fee)
Novartis Pharma AG (Early Access Subscriber) (Multiyear fee)
Pharmacia & Upjohn (Early Access Subscriber) (Multiyear fee)
Pfizer (Multiyear fee)
Takeda Chemical Industries, LTD (Multiyear fee)
American Home Products (Multiyear fee)
Immunex Corporation (Fees + Royalties)
Valigen
Genset
AMDec
Arena Pharmaceuticals
Vita Genomics (Taiwan)
Educational Customers (In rough order of signing):
Vanderbilt
Harvard
University of Texas Southwestern Medical Center in Dallas
University of Cincinatti
Ohio State University
The Government of Australia (for all Australian universities?)
Howard Hughes Medical Institute
The Institute for Genomic Research (TIGR)
Weizmann Institute of Science
Hospital for Sick Children, Toronto
California Institute of Technology
Max Planck Society
Koronlinska Institutet
Center of Excellence Program at the University of Tokyo
University of California (10 campuses plus 3 DOE labs)
Emory University (Georgia)
Van Andel Institute (Michigan)
Andersen Cancer Center-Houston, Univ of Texas (added to existing agreement with Univ of Texas Southwestern Medical Center-Dallas)
Research Collaborations:
Rhone-Poulenc Rorer (Therapeutic targets for cancer, asthma, cardiovascular, etc)
Gemini Research (Gene discovery)
RhoBio (Gene discovery for Maize, including royalties on developed products)
University of California @ Berkeley (fruit fly)
City of Hope (Breast Cancer)
Geron Corporation (small molecule therapeutics, proteins, cell and gene therapy, stem cells, etc)
Life Technologies, Inc. (Gene and DNA cloning)
Vialactia Biosciences (Bovine gene discovery)
Diversa (Sequence genomes of uncultured organisms)
LION Biosciences (Celera Discovery System tools)
Sandia National Laboratory/Compaq (next generation hardware/software)
Gemini Genomics (50/50 Collaboration on ?? )
Institut de Rechereche Pierre Fabre (Breast cancer)
Lynx (software and database)
National Institutes for Health -seq. rat genome
Acquired Companies/Technologies
MAG Panther ( 100 %acquisition)
Shanghai Genecore Biotechnologies (49% acquisition)
Paracel Inc. (100% Acquisition)(Genematcher
Hubit Genomics - Japan (minority interest) |
